Immunocytochemical Accumulation of p53 in Corticotroph Adenomas: Relationship with Heat Shock Proteins and Apoptosis

Pituitary

Volumn 1, Issue 3-4, 1999, Pages 207-212

  Kontogeorgos, George ^a,d   Kapranos, Nikiforos ^b   Thodou, Eleni ^a   Sambaziotis, Demetrios ^a   Tsagarakis, Stylianos ^c  

^a George Gennimatas ^*  (Greece)

^b Amalia Fleming Memorial Hospital   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d KAT HOSPITAL   (Greece)

Author keywords

Apoptosis; Corticotroph adenomas; Heat shock proteins; p53

Indexed keywords

CORTICOTROPIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; PROTEIN P53;

ADENOMA; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CUSHING SYNDROME; HUMAN; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; METABOLISM; NELSON SYNDROME; PATHOLOGY;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; APOPTOSIS; CUSHING SYNDROME; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NELSON SYNDROME; PITUITARY NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033122835     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1009929704018     Document Type: Article

References (22)

1. Pei L, Melmed S, Scheithauer BW, Kovacs K, Prager D. H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 1994;78:842-846.
2. Li FP, Fraumeni JF. Prospective study of a cancer family syndrome. JAMA 1982;247:2692-2694.
3. Varley JM, Evans DGR, Birch JM. Li-Fraumeni syndrome - A molecular and clinical review. Br J Cancer 1997;76:1-14.
4. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
5. Levin AJ, Momand J, Finaly CA. The p53 tumor suppressor gene. Nature 1991;351:453-356.
6. Herman V, Drazin NZ, Gonsky R, Melmed S. Molecular screening of pituitary adenomas and rearrangements. J Clin Endocrinol Metab 1993;77:50-55.
7. Shaw PH. The role of p53 in cell cycle regulation. Path Res Pract 1996;192:669-675.
8. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN. p53 protein accumulates in Cushing's adenomas and invasive non-functioning adenomas. J Clin Endocrinol Metab 1994;79:1513-1516.
9. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996;38:765-771.
10. Pinhashi-Kimhi O, Michalovitz D, Ben-Zeev A, Oren M. Specific interaction between the p53 cellular tumor antigen and major heat shock proteins. Nature 1986;320:182-185.
11. Koskinen PJ, Sistonen L, Evan G, Morimoto R, Alitalo K. Nuclear organization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells. J Virol 1991;65:842-851.
12. Lehman TA, Bennett WP, Metcalf RA Welch JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI, Harris CC. p53 mutations, ras mutations and p53-heat-shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 1991;51:4090-4096.
13. Kontogeorgos G, Stefaneanu L, Kovacs K. Stress-response proteins in human pituitary adenomas: Expression of heat-shock protein 72. Endocrine 1997a:25-29.
14. Kontogeorgos G, Sambaziotis D, Karameris G, Piaditis G. Apoptosis in human pituitary adenomas: a morphologic study and in situ-end labeling study. Mod Pathol 1997b;10:921-926.
15. Vojtesek B, Bartek J, Midgley CA, Varley DP. An immunohistochemical analysis of the human nuclear phospho protein p53. J Immunol Meth 1992;151:237-244.
16. Green VL, White MC, Hipkin LJ, Jeffreys RV, Foy PM, Atkin SL. Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas. Eur J Endocrinol 1997;136:382-387.
17. Schlamp CL, Poulsen GL, Nork TM, Nickells RW. Nuclear exclusion of wild-type p53 in immortalized hunan retinoblastoma cells. J Natl Cancer Inst 1997;89:1530-1536.
18. Finaly CA, Hinds PW, Tan T-H, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsp 70-p53 complex with an altered half-life. Mol Cell Biol 1988;8:531-539.
19. Levy A, Hall Yeudall WA, Lightman SL. p53 gene mutations in pituitary adenomas: Rare events. Clin Endocrinol (Oxf) 1994;41:809-814.
20. Batiffora H. p53 immunoreactivity: A word of caution. Hum Pathol 1994;25:435-436.
21. Bukulmez G, Kaplan L, Delios L, Gutierrez LS. Discordant p53 overexpression on frozen and paraffin sections in breast carcinomas. Potential false positive results with antigen retrieval methods (abstract). Mod Pathol 1997;1058, 180A
22. Goldman SC, Chen C-Y, LansingTJ, GilmerTM, Kastan MB. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Am J Pathol 1997;148:1381-1385.